Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized blinded study of percutaneous autologous skeletal myoblast implantation in chronic myocardial infarction
2006-000679-14Phase 2Completed
- Sponsor
- Cima Universidad de Navarra
- Start
- Jun 2006
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of autologous skeletal myoblasts in myocardial infarction (MI) (2 arms), sponsored by Cima Universidad de Navarra. Primary endpoints: Global and regional cardiac function, Cardiac function by magnetic resonance imaging and 1 more. Started Jun 2006; status: completed.
02
Drugs
autologous skeletal myoblasts
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on 2006-000679-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000679-14.